Effects of Japanese herbal medicine, Kampo, on human UGT1A1 activity

Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 3, 2009, Pages 226-234

  Katoh, Miki ^a,b   Yoshioka, Yuko ^a   Nakagawa, Nao ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Drug interaction; Herbal medicine; Inhibition; Kampo; Phase II metabolism; UGT

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ANGELICA ROOT EXTRACT; ATRACTYLODES EXTRACT; BAICALIN; BUPLEURUM ROOT EXTRACT; CINNAMALDEHYDE; CINNAMIC ACID; CINNAMON EXTRACT; EMODIN; ESTRADIOL; GINGER EXTRACT; GINSENG EXTRACT; GLUCURONOSYLTRANSFERASE 1A1; GLYCYRRHETINIC ACID; GLYCYRRHIZA EXTRACT; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; HOELEN EXTRACT; JUJUBE EXTRACT; KAMPO; PAEONIA RADIX; PINELLIA EXTRACT; PLANT EXTRACT; PLATYCODON EXTRACT; RHEIN; RHUBARB EXTRACT; SCUTELLARIAE RADIX; SENNOSIDE A; UNCLASSIFIED DRUG; UNINDEXED DRUG; WOGONIN;

ARTICLE; CATALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; FRUIT; HERB; HOELEN; HUMAN; HUMAN CELL; IN VITRO STUDY; JAPANESE; LIVER MICROSOME; MICROSOME; PLANT ROOT; PLATYCODON; RHIZOME; RHUBARB;

EID: 69949158570     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.24.226     Document Type: Article

References (34)

1. Nakajima, S., Tohda, Y., Ohkawa, K., Chihara, J. and Nagasaka, Y.: Effect of saiboku-to (TJ-96) on bronchial asthma. Induction of glucocorticoid receptor, beta-adrenaline receptor, IgE-Fc epsilon receptor expression and its effect on experimental immediate and late asthmatic reaction. Ann. N Y Acad. Sci., 685: 549-560 (1993).
2. Cyong, J. C., Ki, S. M., Iijima, K., Kobayashi, T. and Furuya, M.: Clinical and pharmacological studies on liver diseases treated with Kampo herbal medicine. Am. J. Chin. Med., 28: 351-360 (2000).
3. Naito, T., Itoh, H. and Takeyama, M.: Effects of Hange-kobokuto (Banxia-houpo-tang) on neuropeptide levels in human plasma and saliva. Biol. Pharm. Bull., 26: 1609-1613 (2003).
4. Ikegami, F., Fujii, Y. and Satoh, T.: Toxicological considerations of Kampo medicines in clinical use. Toxicology, 198: 221-228 (2004).
5. Ikegami, F., Fujii, Y., Ishihara, K. and Satoh, T.: Toxicological aspects of Kampo medicines in clinical use. Chem. Biol. Interact., 145: 235-250 (2003).
6. Stormer, F. C., Reistad, R. and Alexander, J.: Glycyrrhizic acid in liquorice - evaluation of health hazard. Food Chem. Toxicol., 31: 303-312 (1993).
7. Takasuna, K., Hagiwara, T., Watanabe, K., Onose, S., Yoshida, S., Kumazawa, E., Nagai, E. and Kamataki, T.: Optimal antidiar-rhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea. Cancer Chemother. Pharmacol., 58: 494-503 (2006).
8. Zhou, S., Gao, Y., Jiang, W., Huang, M., Xu, A. and Paxton, J. W.: Interactions of herbs with cytochrome P450. Drug Metab. Rev., 35: 35-98 (2003).
9. Takahashi, K., Uejima, E., Morisaki, T., Takahashi, K., Kurokawa, N. and Azuma, J.: In vitro inhibitory effects of Kampo medicines on metabolic reactions catalyzed by human liver microsomes. J. Clin. Pharm. Ther., 28: 319-327 (2003).
10. Akao, T., Kawabata, K., Yanagisawa, E., Ishihara, K., Mizuhara, Y., Wakui, Y., Sakashita, Y. and Kobashi, K.: Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J. Pharm. Pharmacol., 52: 1563-1568 (2000).
11. Ando, Y., Saka, H., Ando, M., Sawa, T., Muro, K., Ueoka, H., Yokoyama, A., Saitoh, S., Shimokata, K. and Hasegawa, Y.: Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res., 60: 6921-6926 (2000).
12. Zucker, S. D., Qin, X., Rouster, S. D., Yu, F., Green, R. M., Keshavan, P., Feinberg, J. and Sherman, K. E.: Mechanism of indinavir-induced hyperbilirubinemia. Proc. Natl. Acad. Sci. USA, 98: 12671-12676 (2001).
13. Katoh, M., Matsui, T. and Yokoi, T.: Glucuronidation of antiallergic drug, tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite. Drug Metab. Dispos., 35: 583-589 (2007).
14. Hibino, T., Yuzurihara, M., Terawaki, K., Kanno, H., Kase, Y. and Takeda, A.: Goshuyuto, a traditional Japanese medicine for migraine, inhibits platelet aggregation in Guinea-pig whole blood. J. Pharmacol. Sci., 108: 89-94 (2008).
15. Shiratani, H., Katoh, M., Nakajima, M. and Yokoi, T.: Species differences in UDP-glucuronosyltransferase activities in mice and rats. Drug Metab. Dispos., 36: 1745-1752 (2008).
16. Hanioka, N., Jinno, H., Nishimura, T., Ando, M., Ozawa, S. and Sawada, J.: High-performance liquid chromatographic assay for glucuronidation activity of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes. Biomed. Chromatogr., 15: 328-333 (2001).
17. Strassburg, C. P., Manns, M. P. and Tukey, R. H.: Expression of the UDP-glucuronosyltransferase 1A locus in human colon. J. Biol. Chem., 273: 8719-8726 (1998).
18. Lévesque, E., Girard, H., Journault, K., Lépine, J. and Guillemette, C.: Regulation of the UGT1A1 bilirubin-conjugating pathway: Role of new splicing event at the UGT1A loucus. Hepatology, 45: 128-138 (2007).
19. Gagné, J. F., Montminy, V., Belanger, P., Journault, K., Gaucher, G. and Guillemette, C.: Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol. Pharmacol., 62: 608-617 (2002).
20. Lépine, J., Bernard, O., Plante, M., Têtu, B., Pelletier, G., Labrie, F., Bélanger, A. and Guillemette, C.: Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human Uridine diphospho-glucuronosyltransferases expressed in endometrium. J. Clin. Endocrinol. Metab., 89: 5222-5232 (2004).
21. Kondo, K., Shiba, M., Nakamura, R., Morota, T. and Shoyama, Y.: Constituent properties of licorices derived from Glycyrrhiza uralensis, G. glabra, or G. inflata identified by genetic information. Biol. Pharm. Bull., 30: 1271-1277 (2007).
22. Gong, F., Liang, Y. Z. and Fung, Y. S.: Analysis of volatile components from Cortex cinnamomi with hyphenated chromatography and chemometric resolution. J. Pharm. Biomed. Anal., 34: 1029-1047 (2004).
23. Wang, Y. C. and Yang, Y. S.: Simultaneous quantification of flavonoids and triterpenoids in licorice using HPLC. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 850: 392-399 (2007).
24. Li, H. B., Jiang, Y. and Chen, F.: Separation methods used for Scutellaria baicalensis active components. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 812: 277-290 (2004).
25. Yokoi, T., Narita, M., Nagai, E., Hagiwara, H., Aburada, M. and Kamataki, T.: Inhibition of UDP-glucuronosyltransferase by aglycons of natural glucuronides in kampo medicines using SN-38 as a substrate. Jpn. J. Cancer Res., 86: 985-989 (1995).
26. Zhang, L., Lin, G. and Zuo, Z.: Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein. Pharm. Res., 24: 81-89 (2007).
27. Koyama, J., Morita, I., Fujiyoshi, H. and Kobayashi, N.: Simultaneous determination of anthraquinones, their 8-β-D-glucosides, and sennosides of Rhei Rhizoma by capillary electrophoresis. Chem. Pharm. Bull. (Tokyo), 53: 573-575 (2005).
28. Lemli, J. and Lemmens, L.: Metabolism of sennosides and rhein in the rat. Pharmacology, 20 Suppl 1: 50-57 (1980).
29. Rios, G. R. and Tephly, T. R.: Inhibition and active sites of UDP-glucuronosyltransferases 2B7 and 1A1. Drug Metab. Dispos., 30: 1364-1367 (2002).
30. Foti, R. S., Wahlstrom, J. L. and Wienkers, L. C.: The in vitro drug interaction potential of dietary supplements containing multiple herbal components. Drug Metab. Dispos., 35: 185-188 (2007).
31. Muto, R., Motozuka, T., Nakano, M., Tatsumi, Y., Sakamoto, F. and Kosaka, N.: The chemical structure of new substance as the metabolite of baicalin and time profiles for the plasma concentration after oral administration of sho-saiko-to in human. Yakugaku Zasshi, 118: 79-87 (1998).
32. Lee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H. and Zhu, B. T.: Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology., 144: 3382-3398 (2003).
33. Senafi, S. B., Clarke, D. J. and Burchell, B.: Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem. J., 303: 233-240 (1994).
34. D'Andrea, V., Pérez, L. M. and Sánchez Pozzi, E. J.: Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide. Life Sci., 77: 683-692 (2005).